CompletedNot Applicable

Lesion Site and Neglect Anosognosia in Patients With Left Hemispatial Neglect

Turkey (Türkiye)78 participantsStarted 2022-12-16

Plain-language summary

The goal of this retrospective is to investigate the relationship between lesion site and neglect anosognosia in subacute or chronic right hemispheric stroke patients with left hemispatial neglect. The main questions it aims to answer are: * Was any lesion site related to a higher neglect anosognosia rate? * Did any lesion site related to a more severe neglect anosognosia? Participants will be divided into two groups regarding the presence of anosognosia for spatial neglect. Researchers will compare patients with and without anosognosia to see if any lesion site resulted in a higher anosognosia rate and more severe unawareness of neglect symptoms in daily life.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being older than 18 years of age * Having a subacute or chronic right hemispheric supratentorial stroke * Having left hemispatial neglect Exclusion Criteria: * Being in the first 2 weeks of the stroke * Lesions involving the left hemisphere and/or brainstem and/or cerebellum * Having other neurological conditions such as traumatic brain injury, central nervous system neoplasm, neurodegenerative or neuropsychiatric diseases * Presence of severe cognitive impairment in the mini-mental state examination scale (\<10 points) * Lack of brain imaging data * Having visual problems and psychiatric disorders hindering neglect and anosognosia evaluation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Neglect Score on Catherine Bergego Scale (CBS)

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Neglect Anosognosia Score on Catherine Bergego Scale (CBS)

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Lesion site-cortical involvement

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Lesion site-regions of interest

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Lesion pervasiveness

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Trial details

NCT IDNCT05654350

SponsorGazi University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-20

View on ClinicalTrials.gov More Anosognosia trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Neglect Score on Catherine Bergego Scale (CBS)

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Neglect Anosognosia Score on Catherine Bergego Scale (CBS)

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Lesion site-cortical involvement

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Lesion site-regions of interest

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic

Lesion pervasiveness

Timeframe: Within the first week of admission to the inpatient rehabilitation clinic